[1]
“The Effect of N-Acetylcysteine as Adjuvant Therapy of Hypoxemia in COVID-19 Patients, Assessed by Interleukin-6 Level and PaO2/FiO2Ratio”, J Respirol Indones, vol. 42, no. 3, pp. 226–236, Jul. 2022, doi: 10.36497/jri.v42i3.227.